Brief: A1M Pharma Proposes Rights Issue Of About SEK 83 Million
Feb 5 (Reuters) - A1M PHARMA AB A1M.ST :
* PROPOSES RIGHTS ISSUE OF ABOUT SEK 83 MILLION BEFORE ISSUE
COSTS
TO FINANCE CLINICAL STUDIES
* SUBSCRIPTION PRICE IS SEK 5 PER NEW SHARE
* ISSUE IS SECURED TO 75 PERCENT CORRESPONDING TO SEK 62.3
MILLION
Source text for Eikon: ID:nBQN2tjRSN
Further company coverage: A1M.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover